• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体 α 和 β 以及芳香酶作为前列腺癌结局的独立预测因子。

Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome.

机构信息

Dept. of Medical Biology, UiT The Arctic University of Norway, Tromso, Norway.

Dept. of Clinical Medicine, UiT The Arctic University of Norway, Tromso, Norway.

出版信息

Sci Rep. 2016 Sep 9;6:33114. doi: 10.1038/srep33114.

DOI:10.1038/srep33114
PMID:27610593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5017140/
Abstract

Androgens are considered important in normal prostate physiology and prostate cancer (PCa) pathogenesis. However, androgen-targeted treatment preventing PCa recurrence is still lacking. This indicates additional mediators contributing to cancer development. We sought to determine the prognostic significance of estrogen receptors, ERα and -β, and the aromatase enzyme in PCa. Tissue microarrays were created from 535 PCa patients treated with radical prostatectomy. Expression of ERα, ERβ and aromatase were evaluated using immunohistochemistry. Representative tumor epithelial (TE) and tumor stromal (TS) areas were investigated separately. Survival analyses were used to evaluate the markers correlation to PCa outcome. In univariate analyses, ERα in TS was associated with delayed time to clinical failure (CF) (p = 0.042) and PCa death (p = 0.019), while ERβ was associated with reduced time to biochemical failure (BF) (p = 0.002). Aromatase in TS and TE was associated with increased time to BF and CF respectively (p = 0.016, p = 0.046). Multivariate analyses supported these observations, indicating an independent prognostic impact of all markers. When stratifying the analysis according to different surgical centers the results were unchanged. In conclusion, significant prognostic roles of ERα, ERβ and aromatase were discovered in the in PCa specimens of our large multicenter cohort.

摘要

雄激素被认为在正常前列腺生理和前列腺癌(PCa)发病机制中起重要作用。然而,仍然缺乏针对雄激素的治疗方法来预防 PCa 的复发。这表明还有其他促进癌症发展的介质。我们试图确定雌激素受体 ERα 和 -β 以及芳香酶在 PCa 中的预后意义。从接受根治性前列腺切除术治疗的 535 名 PCa 患者中创建了组织微阵列。使用免疫组织化学评估 ERα、ERβ 和芳香酶的表达。分别研究了代表性的肿瘤上皮(TE)和肿瘤基质(TS)区域。生存分析用于评估标志物与 PCa 结局的相关性。在单因素分析中,TS 中的 ERα 与临床失败(CF)(p = 0.042)和 PCa 死亡(p = 0.019)的延迟时间相关,而 ERβ 与生化失败(BF)(p = 0.002)的时间减少相关。TS 和 TE 中的芳香酶与 BF 和 CF 的时间延长分别相关(p = 0.016,p = 0.046)。多因素分析支持这些观察结果,表明所有标志物均具有独立的预后影响。当根据不同的手术中心对分析进行分层时,结果保持不变。总之,在我们的大型多中心队列的 PCa 标本中发现了 ERα、ERβ 和芳香酶具有显著的预后作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5017140/2a1bdf22cef7/srep33114-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5017140/d7014a65f804/srep33114-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5017140/2a1bdf22cef7/srep33114-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5017140/d7014a65f804/srep33114-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c28/5017140/2a1bdf22cef7/srep33114-f2.jpg

相似文献

1
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome.雌激素受体 α 和 β 以及芳香酶作为前列腺癌结局的独立预测因子。
Sci Rep. 2016 Sep 9;6:33114. doi: 10.1038/srep33114.
2
Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.正常体重和肥胖前列腺癌患者中雄激素和雌激素相关蛋白的表达
Prostate. 2009 Apr 1;69(5):520-7. doi: 10.1002/pros.20901.
3
Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population.在希腊城市人群中,前列腺切除术后T3N0M0局部晚期前列腺癌患者的雌激素受体(α和β)而非雄激素受体的表达与复发、进展和生存相关。
Asian J Androl. 2015 Jan-Feb;17(1):98-105. doi: 10.4103/1008-682X.136445.
4
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.雌激素受体α、β及芳香化酶表达在非小细胞肺癌中的预后相关性
Steroids. 2016 Sep;113:5-13. doi: 10.1016/j.steroids.2016.05.008. Epub 2016 May 24.
5
Expression Patterns of ERα, ERβ, AR, SIRT1, SIRT2, and SIRT3 in Prostate Cancer Tissue and Normal Prostate Tissue.在前列腺癌组织和正常前列腺组织中 ERα、ERβ、AR、SIRT1、SIRT2 和 SIRT3 的表达模式。
Anticancer Res. 2021 Mar;41(3):1377-1386. doi: 10.21873/anticanres.14895.
6
Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor.人睾丸间质细胞瘤中芳香化酶和雌激素受体(ERα、ERβ1、ERβ2)的检测
Eur J Endocrinol. 2007 Aug;157(2):239-44. doi: 10.1530/EJE-07-0029.
7
The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?地塞米松对培养的人真皮乳头细胞中芳香化酶和雌激素受体α的调节作用:雌激素通过雌激素受体β发挥选择性作用的新机制?
J Invest Dermatol. 2006 Sep;126(9):2010-8. doi: 10.1038/sj.jid.5700344. Epub 2006 May 11.
8
Discovery of a multi-target compound for estrogen receptor-positive (ER) breast cancer: Involvement of aromatase and ERs.发现一种针对雌激素受体阳性(ER)乳腺癌的多靶化合物:涉及芳香酶和 ERs。
Biochimie. 2021 Feb;181:65-76. doi: 10.1016/j.biochi.2020.11.023. Epub 2020 Dec 3.
9
Aromatase and estrogen receptor alpha mRNA expression as prognostic biomarkers in patients with astrocytomas.芳香化酶和雌激素受体α mRNA表达作为星形细胞瘤患者的预后生物标志物
J Neurooncol. 2014 Sep;119(2):275-84. doi: 10.1007/s11060-014-1509-z. Epub 2014 Jul 9.
10
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.TMEFF2 调控的细胞周期相关基因特征可预测前列腺癌的复发风险。
BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.

引用本文的文献

1
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease.追踪前列腺癌和膀胱癌中性激素的演变以及受体介导的免疫微环境差异:从胚胎发育到疾病
Adv Sci (Weinh). 2025 Apr;12(13):e2407715. doi: 10.1002/advs.202407715. Epub 2025 Feb 25.
2
Histopathological analysis potential for unveiling hormone signaling in endocrine-related tumors.组织病理学分析在揭示内分泌相关肿瘤中的激素信号传导方面的潜力。
Endocr Oncol. 2024 Aug 29;4(1):e240033. doi: 10.1530/EO-24-0033. eCollection 2024 Jan 1.
3
Genes Co-Expressed with Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis.

本文引用的文献

1
Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.细胞质 ERβ1 和核 ERβ2 的前列腺癌表达谱与根治性前列腺切除术后的不良预后相关。
J Urol. 2016 Jun;195(6):1760-6. doi: 10.1016/j.juro.2015.12.101. Epub 2016 Jan 22.
2
Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.癌相关成纤维细胞中的雌激素受体α通过减少肿瘤微环境中的CCL5、IL6和巨噬细胞浸润来抑制前列腺癌侵袭。
Mol Cancer. 2016 Jan 20;15:7. doi: 10.1186/s12943-015-0488-9.
3
与癌症患者临床结局相关的基因共表达分析:TCGA 数据分析。
Int J Mol Sci. 2024 Aug 9;25(16):8707. doi: 10.3390/ijms25168707.
4
Differences in the expression of the phosphatase PTP-1B in patients with localized prostate cancer with and without adverse pathological features.具有和不具有不良病理特征的局限性前列腺癌患者中磷酸酶PTP-1B表达的差异。
Front Oncol. 2024 Apr 19;14:1334845. doi: 10.3389/fonc.2024.1334845. eCollection 2024.
5
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.前列腺癌中的核雌激素受体:从基因到功能
Cancers (Basel). 2023 Sep 20;15(18):4653. doi: 10.3390/cancers15184653.
6
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.ESR2 多态性与前列腺癌风险:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Jun 9;102(23):e33937. doi: 10.1097/MD.0000000000033937.
7
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants.犬前列腺癌与人前列腺癌变体之间的分子异同
Biomedicines. 2023 Apr 5;11(4):1100. doi: 10.3390/biomedicines11041100.
8
Targeting the formation of estrogens for treatment of hormone dependent diseases-current status.针对雌激素形成用于治疗激素依赖性疾病的现状
Front Pharmacol. 2023 Apr 28;14:1155558. doi: 10.3389/fphar.2023.1155558. eCollection 2023.
9
Lifelong exercise training promotes the remodelling of the immune system and prostate signalome in a rat model of prostate carcinogenesis.终身运动训练可促进前列腺癌发生大鼠模型中免疫系统和前列腺信号组的重塑。
Geroscience. 2024 Feb;46(1):817-840. doi: 10.1007/s11357-023-00806-5. Epub 2023 May 12.
10
The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches.雌激素受体α和β在去势抵抗性前列腺癌中的作用及当前治疗方法
Biomedicines. 2023 Mar 9;11(3):826. doi: 10.3390/biomedicines11030826.
Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer.
托瑞米芬的纳米靶向递送,一种前列腺癌中的雌激素受体-α阻滞剂
Pharm Res. 2015 Aug;32(8):2764-74. doi: 10.1007/s11095-015-1662-x. Epub 2015 Mar 12.
4
Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies.前列腺癌已发表的免疫组化预后生物标志物的全面验证——哪里出了问题?生物标志物研究前进方向的蓝图。
Br J Cancer. 2015 Jan 6;112(1):140-8. doi: 10.1038/bjc.2014.588. Epub 2014 Nov 25.
5
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
6
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.挪威北部根治性前列腺切除术的特定疾病结局;探讨神经周围浸润和术后 PSA 倍增时间的影响。
BMC Urol. 2014 Jun 14;14:49. doi: 10.1186/1471-2490-14-49.
7
Enzalutamide in metastatic prostate cancer before chemotherapy.恩杂鲁胺治疗化疗前转移性前列腺癌。
N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1.
8
Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.CYP19A1 基因中功能性遗传多态性对前列腺癌风险和生存的影响。
Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952. Epub 2014 May 20.
9
Decreased expression of stromal estrogen receptor α and β in prostate cancer.前列腺癌中基质雌激素受体 α 和 β 的表达降低。
Am J Transl Res. 2014 Jan 15;6(2):140-6. eCollection 2014.
10
Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.癌相关成纤维细胞中的雌激素受体α通过调节血小板反应蛋白2和基质金属蛋白酶3来抑制前列腺癌侵袭。
Carcinogenesis. 2014 Jun;35(6):1301-9. doi: 10.1093/carcin/bgt488. Epub 2013 Dec 28.